The FDA approved tavapadon (Juvmo) on September 25, 2026, introducing a new once-daily medication for adults living with Parkinson’s disease.
Tavapadon helps manage movement symptoms, including tremors, stiffness, and slowed movement. Clinical trials demonstrated benefits for people with both earlier and progressing Parkinson’s.
For families, this approval offers another treatment option worth understanding, especially when a loved one’s symptoms are becoming harder to manage.
Key Takeaways About Tavapadon
- New FDA-approved medication: Tavapadon, marketed as Juvmo, is a once-daily pill for adults with Parkinson’s disease.
- Improved movement: Clinical trials showed improvements in motor symptoms and daily functioning.
- More time with controlled symptoms: Adding tavapadon to levodopa provided approximately one additional hour of good symptom control each day, on average.
- Important safety considerations: Side effects may include nausea, dizziness, sleepiness, hallucinations, and behavioral changes.
- Individualized treatment: Tavapadon is not a cure. Its suitability depends on each person’s symptoms, medical history, and existing medications.
Tavapadon vs. Levodopa: What Is the Difference?
Both medications help manage Parkinson’s motor symptoms, but they work differently.
| Tavapadon (Juvmo) | Levodopa | |
| How it works | Mimics dopamine activity at selected brain receptors | Is converted into dopamine in the brain |
| Treatment role | Can be used alone or alongside levodopa | Commonly prescribed to manage motor symptoms |
| Administration | Once-daily oral medication | Dosing frequency depends on the formulation and prescription |
Tavapadon expands existing treatment choices. It is not necessarily more effective or appropriate than levodopa for every individual.
Exploring Parkinson’s Care for Someone You Love?
At Kensington Park Senior Living, we understand how Parkinson’s can affect everyday life. Our personalized care approach helps residents maintain comfort, dignity, and independence as their needs change.
Explore Parkinson’s Assisted Living in Maryland
What Is Tavapadon, and How Does It Work?
Tavapadon belongs to a class of Parkinson’s medications called dopamine agonists. These medications mimic the effects of dopamine, a neurotransmitter involved in controlling movement.
Parkinson’s disease gradually reduces dopamine-producing cells in the brain.
As dopamine levels decline, individuals may experience:
- Tremors in the hands, arms, or legs
- Muscle stiffness and rigidity
- Slower movements
- Difficulty initiating movement
- Changes in walking and coordination
Unlike levodopa, which the body converts into dopamine, tavapadon directly stimulates certain dopamine receptors.
What Makes Tavapadon Different?
Tavapadon is designed to act more selectively on dopamine receptors associated with movement.
Earlier dopamine agonists also affect receptors involved in reward and alertness. This broader activity can contribute to unwanted side effects. Researchers believe tavapadon’s more targeted action may offer tolerability advantages.
However, tavapadon has not been directly compared with older dopamine agonists to establish whether it causes fewer side effects.
According to The Michael J. Fox Foundation, tavapadon was studied both independently and alongside levodopa.
What Benefits Did Tavapadon Show in Clinical Trials?
Tavapadon demonstrated improvements in movement symptoms and everyday functioning during the Phase III TEMPO clinical trial program.
Three studies contributed evidence supporting its FDA approval.
TEMPO-1 and TEMPO-2: Earlier Parkinson’s Disease
These studies involved individuals diagnosed with Parkinson’s within the previous three years who were not taking dopamine medications.
Compared with placebo, tavapadon improved motor symptoms and measures of daily functioning.
Researchers evaluated tasks such as:
- Getting dressed
- Walking and moving around
- Eating
- Managing personal hygiene
These results suggest tavapadon may be useful as a treatment option during earlier Parkinson’s.
TEMPO-3: Parkinson’s with Motor Fluctuations
TEMPO-3 evaluated tavapadon in individuals already taking levodopa who experienced changes in symptom control throughout the day.
Participants receiving tavapadon experienced approximately 1 additional hour of daily on-time without troublesome dyskinesia, on average, compared with those receiving placebo.
They also experienced approximately 1 hour less time off.
What Do On Time and Off Time Mean?
- On time: Periods when Parkinson’s movement symptoms are adequately controlled by medication.
- Off time: Periods when medication benefits wear off or become less effective, allowing symptoms to return.
Dyskinesia refers to involuntary movements that can occur with Parkinson’s treatment. For a loved one experiencing unpredictable off time, better symptom control may create more opportunities to complete daily activities comfortably.
An additional hour could be meaningful for enjoying a meal, spending time with family, or getting ready for the day.
However, clinical trial findings represent average results. Individual responses may vary.
What Side Effects Should Families Know About?
Tavapadon was generally well tolerated in clinical trials, but it can cause side effects that families should be aware of.
The most commonly reported effects included:
- Nausea
- Headache
- Dizziness
Other important concerns include sleepiness, hallucinations, impulse control changes, and low blood pressure when standing.
Individuals taking tavapadon alongside levodopa may also experience involuntary movements.
Why Monitoring Matters for Older Adults
Certain medication side effects can complicate existing Parkinson’s challenges.
For example, dizziness or low blood pressure may increase the risk of falls. Unusual sleepiness can interfere with daily routines, while hallucinations or behavioral changes may be upsetting.
Families can help by watching for changes in:
- Balance: New dizziness, stumbling, or falls
- Alertness: Excessive sleepiness or sudden episodes of falling asleep
- Behavior: Hallucinations, confusion, or new compulsive behaviors
- Movement: New or worsening involuntary movements
Report concerning changes promptly to the prescribing clinician.
Researchers are continuing to study tavapadon’s longer-term safety through the TEMPO-4 study.
Never stop or change Parkinson’s medication without guidance from the prescribing clinician.
Is Tavapadon Right for Your Loved One?
Tavapadon may be worth discussing with a neurologist if your loved one experiences troublesome motor symptoms or inconsistent symptom control.
However, newer does not automatically mean better.
The most appropriate treatment depends on factors such as existing medications, other health conditions, previous side effects, and individual priorities.
Five Questions to Ask the Neurologist
If your family is considering tavapadon, these questions can help guide the conversation:
- Could tavapadon help my loved one’s specific symptoms? Ask whether it is appropriate for their current stage of Parkinson’s.
- Would it be taken alone or with levodopa? Understand how it might fit into the existing treatment plan.
- Which side effects should we watch for? Discuss concerns related to falls, sleepiness, hallucinations, and blood pressure.
- How would we measure improvement? Ask what changes in movement or daily functioning may indicate that treatment is helping.
- Is Juvmo available and covered by insurance? Confirm current prescription access, cost, and coverage.
The FDA approved Juvmo on September 25, 2026. However, commercial availability and insurance arrangements may take additional time.
The goal of any treatment conversation should be to identify what best supports your loved one’s health, comfort, and daily life.
Supporting a Loved One with Parkinson’s Beyond Medication
Medication plays an important role in Parkinson’s care, but it is only one part of managing the disease.
Parkinson’s may also affect balance, speech, swallowing, sleep, mood, and the ability to complete daily routines.
A comprehensive care approach considers these changing needs together.
Essential Areas of Parkinson’s Support
Medication routines
Consistent medication timing is particularly important for Parkinson’s. Missed or delayed doses may contribute to the return of movement symptoms.
Movement and mobility
Appropriate physical activity, mobility assistance, and fall prevention measures can help individuals remain active while addressing safety concerns.
Rehabilitative therapies
Physical, occupational, and speech therapies may support walking, balance, communication, swallowing, and everyday tasks.
Nutrition and hydration
Nutritional support can help address challenges involving appetite, digestion, swallowing, and energy.
Emotional well-being
Meaningful activities and social relationships can help individuals maintain a sense of purpose and connection.
When Should Families Consider Additional Support?
As Parkinson’s progresses, certain changes may signal that more consistent assistance would be helpful.
These may include:
- Difficulty maintaining medication schedules
- Increasing falls or mobility concerns
- Greater dependence on others for dressing or bathing
- Challenges preparing meals or eating safely
- Increased isolation or reduced participation in favorite activities
- Growing demands on family caregivers
Recognizing these changes early allows families to explore options without waiting for an emergency.
For some individuals, assisted living provides a balance of independence and personalized daily support.
Learn more about assisted living at Kensington Park Senior Living and how our community responds to residents’ individual needs.
Not Sure Whether Your Loved One Needs More Support?
We know that Parkinson’s care decisions can feel complicated. Our Kensington Park team members are here to listen, answer your questions, and help you explore the care options that may be right for your family.
Connect with Our Kensington Park Team
Personalized Parkinson’s Care at Kensington Park Senior Living
At Kensington Park, we recognize that Parkinson’s affects each person differently. Our approach combines individualized care planning, around-the-clock licensed nursing support, and rehabilitative services to meet residents’ changing needs.
Just as importantly, we take time to understand each resident’s preferences, routines, and goals.
Individualized Care and Nursing Support
Our team members work closely with residents and their families to provide support that reflects each person’s abilities and care needs.
Depending on a resident’s needs, care may include:
- Medication assistance: Supporting prescribed routines and communicating relevant changes
- Mobility support: Helping residents navigate daily activities with greater confidence
- On-site rehabilitation: Access to physical, occupational, and speech therapy
- Personal care assistance: Helping with dressing, bathing, and other everyday needs
- Family involvement: Keeping loved ones informed and involved in care planning
Supporting Physical and Emotional Well-Being
Alongside personalized care, we provide opportunities for movement, enrichment, and social connection that support residents’ physical and emotional well-being.
Our Parkinson’s therapies and wellness approach includes:
- Rehabilitative services
- Targeted movement activities
- Nutrition
- Emotional support
We also encourage families to stay informed and connected. Explore our upcoming community events for educational programs and caregiver resources.
A Commitment to Caring Like Family
We know that choosing care for someone you love is deeply personal.
Our team members take time to understand each resident’s preferences, abilities, and changing needs. We value the relationships we build with residents and their families.
Our Promise is to love and care for your family as we do our own.
That commitment guides our approach to personalized care, from everyday assistance to supporting families through more complex health changes.
FAQs: Tavapadon for Parkinson’s Disease
No. Tavapadon treats Parkinson’s motor symptoms but has not been shown to cure the disease, reverse neurological damage, or stop its progression. Its purpose is to improve symptom control and support daily functioning.
Yes. Tavapadon was studied alongside levodopa in the TEMPO-3 clinical trial. A neurologist can determine whether this combination is appropriate for your loved one’s symptoms and treatment plan.
Tavapadon may offer tolerability advantages, but studies have not established that it is safer than older dopamine agonists. Families should discuss potential side effects with their loved one’s neurologist.
Tavapadon was studied in people with earlier Parkinson’s and those experiencing motor fluctuations while taking levodopa. These findings do not establish its benefits for every person with advanced disease. A movement disorder specialist can evaluate whether tavapadon is appropriate for someone with more complex symptoms.
Following its recent FDA approval, Juvmo is expected to become available by prescription in the coming months. Families should check with their clinician and pharmacist for current availability, pricing, and insurance coverage.
Discover Compassionate Parkinson’s Support at Kensington Park
The approval of tavapadon is an encouraging step forward for individuals living with Parkinson’s and their families.
As treatment options expand, thoughtful care remains essential to helping people navigate the disease with comfort, dignity, and independence.
Let’s Talk About Your Loved One’s Care
At Kensington Park Senior Living, we are here to support the routines, relationships, and experiences that make each day meaningful.
Whether your family is beginning to explore assisted living or considering additional Parkinson’s support, we welcome the opportunity to help.
Connect with our team members to discuss your loved one’s needs, ask questions, or experience our Kensington community firsthand.
Schedule a Personal Tour or Contact Our Team
This article is for educational purposes and does not replace professional medical advice. Consult a qualified prescribing clinician before starting, stopping, or changing Parkinson’s medication.